Edgar Asebey and Guilherme Ferrari Faviero joined Frier Levitt in its life sciences practice, the firm announced Monday.
Asebey brings more than 20 years of experience in FDA regulatory law, transactional law, and strategic advisory services for life sciences companies. He combines legal and scientific expertise to provide comprehensive guidance to pharmaceutical, biotechnology, food, dietary supplement, cannabis, hemp, and psychedelics companies.
Faviero is a scientist and regulatory expert who advises life sciences companies on compliance, clinical research, and regulatory strategy. Together, they expand the firm’s ability to support clients with cutting-edge scientific insight and legal counsel, the firm said.
This ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.